Type: Observational

Status of the trial: Active, Recruiting

Orphan Drug Recognition: Yes

Inclusion

• Opening Date: 2020-02-01
• Closing Date: 2020-03-01

Criteria

Inclusion: RP with mutations affecting the RHO, PDE6A and PDE6B genes Visual acuity ≥ 20/200 for at least one eye Binocular Visual field diameter ≥ 5° as measured on the Goldmann III-4e isopter

Exclusion: Patients with any other gene mutation known to be involved in RP Patients with other ocular disorder likely to impact the visual function Pregnant or breastfeeding women

More information